Both in Pharmaceuticals
Annexon vs Alumis
Over the past year ANNX returned +32.2% and ALMS returned +42.5%; their daily moves had a correlation of 0.21.
ANNX +32.2% ALMS +42.5%Growth of $1, one year, split-adjusted
| Metric | ANNX | ALMS |
|---|---|---|
| Price | $4.19 | $6.50 |
| Market cap | $794.3M | $841.3M |
| Today | +6.35% | +1.88% |
| 1 month | −0.2% | −5.0% |
| 6 months | −26.7% | −75.1% |
| Year to date | −16.5% | −33.4% |
| 1 year | +32.6% | +36.8% |
| Revenue growth (YoY) | — | −37.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −8557.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 113.7× |
| Net cash | $209.2M | $502.3M |
| Dividend yield | — | — |
| Volatility (60d) | 63.8% | 180.4% |
| Short % of float | 20.6% | 11.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).